F1000Trials news

After consultation with the biomedical community and our Faculty Members, we have concluded that there isn’t sufficient demand to fully launch F1000Trials. We will instead expand the medical coverage in F1000Trials’ sister service F1000Prime, by incorporating some of the content and useful features from F1000Trials within it. This will enable us to provide a more cohesive and comprehensive recommended literature service with F1000Prime.

F1000Trials will cease to be a separate service as of today; however, F1000Trials Faculty Members will now be part of F1000Prime and will continue to write recommendations of articles about clinical trials if they are worthy of inclusion in F1000Prime. Trial articles that were assigned a star rating in F1000Trials can be found in the recommended articles in F1000Prime. Trial articles that were reviewed and were unrated (i.e. without a star rating) in F1000Trials will remain available and linkable via their digital object identifiers (DOIs) and appear in our open access journal F1000Prime Reports.

Where possible article recommendations in F1000Prime will list and link to other articles about the same trial that have been indexed in PubMed – in a threaded publication trail. Links to trial registration databases are also incorporated (see example pictured).

F1000Prime recommendation with publication thread

Registered users of F1000Trials are offered a free 3-month personal subscription to F1000Prime — in case their organization does not subscribe to F1000Prime. Please contact F1000 with any questions about accessing content previously available through F1000Trials.

previous post

Houston, mark your calendars for the next F1000 meet-up!

next post

Introducing F1000's new CEO